Mangalam Global Enterprise Limited has launched NEAT Everyday, a new wellness and personal care brand, with the simultaneous opening of five retail outlets across Ahmedabad on June 04, 2026. This strategic move marks the Group's entry into India's nutraceuticals and wellness sector, leveraging over eight decades of expertise in agriculture and manufacturing. The brand aims to bridge traditional wellness wisdom with modern consumer needs through an omnichannel retail model.

The launch introduces a portfolio of more than 30 products, including oils, soft gels, capsules, and gummies, which are 100% vegan, gluten-free, and paraben-free. NEAT Everyday is built on the philosophy of "Passed Down with Purpose, Delivered with Love," focusing on natural ingredients and cold-pressed purity. The company projects significant growth potential in the Indian market, which is estimated to reach USD 34 billion by 2028, driven by rising demand for preventive healthcare and self-care solutions.

Brand Strategy and Expansion

Vipin Prakash Mangal, Chairman & Executive Director of Group Mangalam, emphasized the vision of combining traditional wellness with current lifestyles. The stores are designed as experiential discovery centres rather than mere retail spaces. Supported by the parent company's legacy of trust, the brand plans to expand into Tier-1 and Tier-2 cities, utilizing both physical stores and digital platforms to enhance accessibility.

Operational Details

The disclosure was submitted to the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The initiative is managed by the promoter group, Honey Mangal and Tanisha Mangal, who highlighted the focus on creating meaningful consumer experiences through informed choices and honest products.

Mangalam Global Enterprise Limited has secured in-principle approval from major Indian stock exchanges for listing equity shares under its employee stock option scheme. The company announced that it has received approvals from both National Stock Exchange of India Limited and BSE Limited for its Employee Stock Option Plan 2026.

Stock Exchange Approvals

The approvals cover the listing of up to 33,00,000 equity shares of Rs. 1/- each to be issued under the Employee Stock Option Plan 2026. Both exchanges granted their approvals under Regulation 28(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Formal Documentation and Communication

The company issued formal communications to both exchanges under reference number MGEL/CS/SE/2026-27/11. Company Secretary Karansingh I. Karki (Mem. No. A30021) signed the official notifications pursuant to Regulation 30 of the SEBI Listing Regulations, confirming receipt of the in-principle approvals.

Compliance Conditions

The in-principle approvals are subject to several mandatory compliance conditions that the company must fulfill. These conditions ensure adherence to regulatory frameworks and protect investor interests.

Key Requirements Include:

• Notification to exchanges as per Regulation 10(c) format after share allotment and crediting to beneficiaries' accounts
• Payment of prescribed fees as determined by the exchanges
• Receipt of all statutory and regulatory approvals from authorities including SEBI, RBI, and MCA
• Compliance with exchange guidelines, regulations, and directions
• Adherence to SEBI LODR Regulations 2015 conditions
• Compliance with Companies Act provisions and other applicable laws

Regulatory Framework

The Employee Stock Option Plan 2026 operates under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company submitted the required statement under Regulation 10(b) along with other necessary documentation to both exchanges.

Exchange Reservations and Final Approval Process

Both NSE and BSE have reserved the right to withdraw their in-principle approvals if any submitted information is found to be incomplete, incorrect, misleading, or false. The exchanges also retain the right to revoke approval for any contravention of rules, bye-laws, regulations, listing agreements, or statutory guidelines.

The exchanges will issue final trading permissions upon receipt of notification under Regulation 10(c) and subject to compliance with all stated conditions. Additional documentation requirements include certified copies of board resolutions, allottee lists, and confirmation from registrar and transfer agents regarding share credit or certificate dispatch.